• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Palatine exits Veincentre in SBO to CBPE

  • Harriet Matthews
  • Harriet Matthews
  • 17 October 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Palatine has sold its stake in UK-based varicose vein treatment clinic chain Veincentre to CBPE Capital.

Palatine acquired a minority stake in Veincentre in July 2019, deploying equity via its 2016-vintage, GBP 100m debut impact fund. The SBO marks the second exit from the fund and follows the sale of apprenticeship scheme provider Estio Training in November 2021.

Unquote sister publication Mergermarket reported in July 2022 that CBPE was in exclusivity to acquire Veincentre following a process led by sell-side adviser Grant Thornton. The business was marketed based on EBITDA of GBP 5m-GBP 6m, as reported.

Veincentre

  • DEAL:

    SBO

  • LOCATION:

    Gloucester

  • SECTOR:

    Health care providers

  • FOUNDED:

    2003

  • EBITDA:

    GBP 5m-6m (est)

  • VENDOR:

    Palatine

During the investment period, Palatine implemented a roll-out strategy for Veincentre, according to a press release. This saw the business grow in size from seven clinics at the time of the initial investment to 22 at the time of exit.

In addition to the roll-out, Veincentre’s revenues grew by 180% and its enquiries from potential patients by 270% during the investment period, according to the same press release.

The GP’s second impact fund made its first investment earlier in October 2022, acquiring UK-based Inclusive Employers, a membership-based organisation that aims to create inclusive workplaces.

CBPE is currently deploying equity via CBPE Capital Fund X, which held a final close on its GBP 561m hard-cap in November 2020. The fund deploys equity tickets of GBP 30m-35m, investing in sectors including financial services, consumer and leisure, and industrials.

The GP’s recent healthcare sector deals include its sale of Rodericks Dental to Capvest in March 2022, which ended a five-year holding period. Mergermarket reported in July 2022 that the GP is expected to explore options for high-end lower limb prosthetics business Blatchford next year, with options including an IPO on the table.

Company
Founded in 2003 and headquartered in Gloucester, Veincentre is a chain of clinics for the treatment of varicose veins. The business offers a non-invasive, non-surgical treatment called Endovenous Laser Ablation (EVLA).

People
Palatine – Beth Houghton (partner, head of the impact fund); James Painter (investment director).
CBPE Capital – Anand Jain (partner).
Veincentre – David West, Deborah West (co-founders).

Advisers
Vendor – Grant Thornton, Pete Terry, Pete Jennings, Duncan Morpeth, Rachael Taplin, Alex Parry (corporate finance); Addleshaw Goddard (legal).
Equity – Eversheds Sutherland (legal)
Management – Rickitt Mitchell (corporate finance).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Healthcare
  • UK / Ireland
  • Secondary buyout
  • Palatine Private Equity
  • Close Brothers Private Equity (CBPE)
  • United Kingdom

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013